A protocol for a discrete choice experiment: understanding preferences of patients with cancer towards their cancer care across metropolitan and rural regions in Australia. by Wong, SF et al.
 
 
 
 
 
 
 
 
Deakin Research Online 
 
This is the published version: 
 
Wong, SF, Norman, R, Dunning, TL, Ashley, DM and Lorgelly, PK 2014, A protocol 
for a discrete choice experiment: understanding preferences of patients with 
cancer towards their cancer care across metropolitan and rural regions in 
Australia., BMJ Open, vol. 4, no. 10, pp. e006661.  
 
 
Available from Deakin Research Online: 
 
http://hdl.handle.net/10536/DRO/DU:30067982 
 
 
Reproduced with the kind permission of the copyright owner. 
This article has been accepted for publication in BMJ Open following peer review and can 
also be viewed on the journal’s website at http://bmjopen.bmj.com/content/4/10/e006661 
 
 
Copyright: 2014, BMJ 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A protocol for a discrete choice
experiment: understanding preferences
of patients with cancer towards their
cancer care across metropolitan and
rural regions in Australia
Shu Fen Wong,1,2 Richard Norman,3,4 Trisha L Dunning,5 David M Ashley,1,2
Paula K Lorgelly6
To cite: Wong SF, Norman R,
Dunning TL, et al. A protocol
for a discrete choice
experiment: understanding
preferences of patients with
cancer towards their cancer
care across metropolitan and
rural regions in Australia.
BMJ Open 2014;4:e006661.
doi:10.1136/bmjopen-2014-
006661
▸ Prepublication history for
this paper is available online.
To view these files please
visit the journal online
(http://dx.doi.org/10.1136/
bmjopen-2014-006661).
Received 17 September 2014
Accepted 30 September 2014
For numbered affiliations see
end of article.
Correspondence to
Dr Shu Fen Wong; shufen.
wong81@gmail.com
ABSTRACT
Introduction: Medical decision-making in oncology is
a complicated process and to date there are few
studies examining how patients with cancer make
choices with respect to different features of their care.
It is also unknown whether patient choices vary by
geographical location and how location could account
for observed rural and metropolitan cancer differences.
This paper describes an ongoing study that aims to (1)
examine patient and healthcare-related factors that
influence choices of patients with cancer; (2) measure
and quantify preferences of patients with cancer
towards cancer care using a discrete choice experiment
(DCE) and (3) explore preference heterogeneity
between metropolitan and rural locations.
Methods and analysis: A DCE is being conducted to
understand how patients with cancer choose between
two clinical scenarios accounting for different patient
and healthcare-related factors (and levels). Preliminary
qualitative research was undertaken to guide the
development of an appropriate DCE design including
characteristics that are important and relevant to
patients with cancer. A fractional factorial design using
the D-efficiency criteria was used to estimate
interactions among attributes. Multinomial logistic
regression will be used for the primary DCE analysis
and to control for sociodemographic and clinical
characteristics.
Ethics and dissemination: The Barwon Health
Human Research Ethics Committee approved the study.
Findings from the study will be presented in national/
international conferences and peer-reviewed journals.
Our results will form the basis of a feasibility study to
inform the development of a larger scale study into
preferences of patients with cancer and their
association with cancer outcomes.
INTRODUCTION
Multiple studies have explored the prefer-
ences of patients living with cancer towards
preventative screening programmes, adjuvant
therapies and information giving in palliative
care.1–4 For example, a recent review of 23
papers published between 1987 and 2003
evaluating patients’ preferences towards adju-
vant therapy in cancer found that there were
four important determinants of their
choices.4 These included the beneﬁts and
toxicities of treatment, experience of the
treatment and whether they had dependants
at home. However, their results were limited
by the small sample sizes of the studies
included in the review and the lack of data
about psychological characteristics and
specialist-related factors.
There are limited contemporary data
about how patients living with cancer in
metropolitan and rural areas make their
Strengths and limitations of this study
▪ To the best of our knowledge, this is the first
study to utilise a discrete choice experiment
(DCE) to measure and quantify preferences of
patients with cancer towards cancer care across
metropolitan and rural regions.
▪ The incorporation of choice task questions will
enable the researchers to elicit how patients with
cancer weigh up their choices and consider
trade-offs between different cancer care options.
▪ It is not feasible to include a complete list of
patient and healthcare-related factors that may
influence choices of patients with cancer in the
DCE. Hence, a mixed qualitative approach was
used to generate a list of factors that are most
relevant and realistic in the current Australian
cancer healthcare system.
▪ Participants are recruited from a mainly
Anglo-Saxon population across a specific region
in Victoria, Australia. The final results of the DCE
may not be applicable to other Australian states.
Wong SF, et al. BMJ Open 2014;4:e006661. doi:10.1136/bmjopen-2014-006661 1
Open Access Protocol
cancer-related decisions relating to diagnosis, investiga-
tions and treatments. Identiﬁed determinants of the
health-seeking behaviour of patients with cancer include
personality and cultural factors,5 6 access to healthcare,7
their socioeconomic status8 and geographical location.9
A large American study5 using data from the 2007
Health Information National Trends Survey (n=1482
rural and 6192 urban residents) found that rural
patients were more likely to have fatalistic beliefs, which
led to the lower likelihood that they would seek medical
care. A study of patients with prostate cancer in rural
Southwest Georgia10 also showed that rural patients who
had a poor therapeutic relationship with their doctors
were less likely to receive treatment after 6 months com-
pared with urban patients.
There are reported deﬁciencies in the provision of
certain healthcare services to rural areas in Australia.7
Rural patients are more likely to travel long distances to
access healthcare services at an inconvenient time and
incur additional out-of-pocket expenses.11 Their cancer-
related decisions may be suboptimal and could result in
worse survival outcomes in rural-remote patients across
Australia.12 For example, Baade et al13 observed that
patients with rectal cancer were more likely to have
higher mortality rates the further away they lived from a
radiotherapy facility (up to 6% for every 100 km dis-
tance). However, these patients’ treatment choices such
as the decline of adjuvant radiotherapy may have traded
quality of life (for themselves and their families) against
their overall outcomes. To date, we can only assume that
these are informed choices, reﬂecting patients’ oppor-
tunity cost, where they choose an alternative option that
they value more.
Although several determinants of health-seeking
behaviour of patients with cancer have been identiﬁed,
few studies to date have compared and validated the
importance of these factors in metropolitan and rural
patients. To the best of our knowledge, the current study
will be the ﬁrst to measure and quantify preferences of
patients with cancer towards cancer care across metro-
politan and rural regions using a discrete choice experi-
ment (DCE).14
This DCE is being conducted across the Barwon
South Western Region (BSWR) in Victoria, Australia.
Participating sites include metropolitan (Andrew Love
Cancer Centre (ALCC), Geelong) and rural
(Warrnambool and Hamilton Hospitals) oncology ser-
vices. The BSWR is reported to have a slightly larger
population of residents over 65 years of age (16.8%)
compared with Victorian statistics (14%), with a subse-
quently higher dependency ratio. 15 The level of cultural
diversity (residents born overseas or with a
non-English-speaking background) across BSWR was low
(13%) and BSWR residents appeared to have a relative
socioeconomic disadvantage compared with Australian
averages.
The methodological details of our ongoing DCE study
are described in this paper.
Aims
The study aims to explore the factors that inﬂuence and
contribute to the decision-making of patients with
cancer regarding their cancer care. The objectives of the
study are:
A. To examine the patient and healthcare-related
characteristics that could inﬂuence the choices of
patients with cancer about their medical care;
B. To elicit how patients with cancer weigh up their
choices and consider trade-offs between different
cancer care options;
C. To determine whether preferences of patients with
cancer vary across metropolitan and rural regions.
METHODS AND ANALYSIS
Overview of approach and methods
Our study utilises both qualitative (focus groups and
one-on-one interviews) and quantitative methods (DCE)
to understand care choices of patients with cancer in a
realistic clinical scenario.
Rationale for using DCE to examine the health-seeking
behaviour of patients with cancer
A variety of methods have been employed to elicit
patients’ healthcare preferences. These methods include
stated preferences (realistic, hypothetical choice scen-
arios) and revealed preferences (real-life choice scen-
arios) methods.16 Recently, DCE has gained popularity
as the model of choice for eliciting stated preferences in
healthcare research,14 including in oncology.17 18 A DCE
enables hypothetical choices incorporating multiple
characteristics to be used to simulate realistic scenarios
(vignettes). A DCE also forces respondents to make
trade-offs among different choice sets, unlike other
methods such as ranking or rating. Consequently, a DCE
enables researchers to gain more in-depth insight into
the relative importance of each characteristic (referred
to as an attribute).19 20
The principle underlying a DCE is that the value of an
option is determined by the value of its attributes.21 The
design consists of a choice-based questionnaire that
enables the simultaneous assessment of multiple attri-
butes presented in the form of a clinical vignette. For
example, Scott et al22 measured the preferences of
parents who had children with respiratory illness, in rela-
tion to out of hours care models in an urban setting.
The choice task involved two consultations described
using the attributes of where the child was seen, whom
the child saw, time taken from phone call to treatment
being received and whether the doctor seemed to listen
to the parents. Levels (eg, 20 min vs 60 min) were
assigned to these attributes (eg, time taken between the
telephone call and treatment being received) to assist
participants to select their preferred choice task option.
Participants chose their preferred consultation type
based on varying attribute-level combinations; thus, the
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authors were able to quantify how these attributes
affected parents’ choices.
DCE developmental process
When designing a DCE, the researchers must determine
the study objectives,; the features (attributes) believed to
deﬁne the topic of interest and decide what types of
models will be used (ﬁgure 1).
Qualitative research prior to DCE
Prior to the DCE design, it is important to undertake
qualitative research that includes a thorough literature
review to establish what is important to key ‘stake-
holders’ to determine the range of attributes and levels
to be included in the ﬁnal DCE design.23 However,
there is little evidence of rigour associated with this
qualitative research and there are some publications
describing how this qualitative research informs the ﬁnal
DCE design. 24
We conducted a literature review that generated a
comprehensive list of factors that inﬂuence the health-
seeking behaviour of patients with cancer towards
cancer care. The list was not meant to be exhaustive;
rather, it guided the development of topic guides to be
used in the semistructured focus groups and telephone
interviews.
A topic guide was used to stimulate discussion about
the features of cancer care that were important to
patients with cancer across rural and metropolitan
regions. Topics for all participants included: (1) the
overall expectations and experiences with the journey of
patients with cancer; (2) knowledge about the patient’s
condition and available treatment options; (3) the avail-
ability of social support networks; (4) the accessibility of
healthcare services including the referral process and
waiting time; (5) the type of health professionals (HPs)
consulted; (6) the location of treatment facility and (7)
the provision of ﬁnancial or emotional resources. It was
envisaged that these topics could potentially but not
necessarily be included in the ﬁnal DCE design.
Focus groups and one-on-one interview methods
Participants in the focus groups and telephone inter-
views included a) English-speaking patients with cancer
presenting to, and b) HPs (both medical and nursing
personnel involved in patient care), employed within
the adult specialist oncology services at BSWR.
There was purposive sampling of participants to
ensure maximum variation across sociodemographic
and clinical characteristics to minimise selection bias.25
Focus groups and telephone interviews were conducted
separately for patient and HP participants by two
researchers (SFW and PKL). Additionally, PKL took
notes during the focus groups. The telephone interviews
were conducted by one researcher (SFW). All interviews
were digitally recorded and transcribed verbatim by a
professional transcriber.
The ﬁnal four focus groups (metropolitan HPs, metro-
politan patients, rural HPs and rural patients) enabled
us to identify a comprehensive range of patient and
healthcare-related characteristics that inﬂuence patient
choices. Nineteen participants (six metropolitan HPs,
six metropolitan patients, three rural HPs and four rural
patients) were involved in the semistructured focus
Figure 1 Key stages for developing a discrete choice experiment.
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groups and two participants (one rural patient and one
rural HP) were engaged in the one-on-one telephone
interviews.
Qualitative analysis of focus groups and one-on-one
interviews
The qualitative data from the audiotaped sessions and
facilitator notes were analysed using the qualitative
method of thematic analysis26 between two authors
(SFW and PKL) and another (TLD) who was not
involved in the literature review or the facilitation of the
focus groups. The transcripts were read and analysed by
the three researchers independently, to identify and
compare all major and minor themes. These themes
were manually summarised in the text and tables before
being interpreted and discussed with coresearchers.27
The themes were subsequently grouped to classify the
similarities and differences between the metropolitan
HPs, metropolitan patients, rural HPs and rural patients.
Our study indicated that the availability of a social
support network, especially family, was of paramount
importance and inﬂuenced patients’ decisions about
seeking or accepting medical attention. The doctor–
patient relationship was also highlighted by patient parti-
cipants as being inﬂuential in time to diagnosis, investi-
gations and treatments. Participants also preferred to
consult an HP who was familiar with their history or who
was perceived to have higher levels of medical
qualiﬁcations.
Potential obstacles to accessing healthcare included
the lack of primary care providers (general practitioners:
GPs) and specialist services in rural areas compared with
metropolitan areas, which may result in delayed medical
attention or referral to a metropolitan facility. Distance
travelled appeared to be of importance for rural
patients. The ﬁnancial costs associated with medical
treatment also posed a signiﬁcant burden to rural
patients who were more likely to have additional
out-of-pocket expenses associated with time away from
work, fuel, car park and accommodation expenses.
The level of health literacy appeared to be inconsist-
ent from the perspectives of both HPs and patients.
Interestingly, differences in the health-seeking behaviour
of patients with cancer were not observed, but HPs
described rural patients as being less passive in their
behaviour compared with metropolitan patients.
Development of attributes and levels for DCE
Six key patient and healthcare-related characteristics that
appeared to be important to patients during their
cancer journey were identiﬁed and included in the
patient choice tasks (vignettes). These attributes were:
(1) whom they consult for their cancer condition; (2)
whether the doctor knows them; (3) the number of
weeks they had to wait to see a doctor; (4) the presence
of family/friends; (5) the distance they had to travel for
their appointment (one-way) and (6) their out-of-pocket
costs in attending an appointment. These attributes
formed the basis of our ﬁnal DCE design. We assigned
levels that patients with cancer could easily relate to and
that were applicable to the current health systems or
potentially available to each attribute.
Recently, it has become common to use prior assump-
tions about parameters rather than to assume, a priori,
that parameters are zero.28–30 The argument in favour of
prior assumptions is that the design is more efﬁcient
because researchers can maximise the information from
each choice set and exclude dominant alternatives.31
We hypothesised that patients with cancer would
prefer to consult a GP they were familiar with or a HP
they felt had higher levels of expertise and experience
compared with another HP. Patients were also more
likely to attend treatment facilities that were easily access-
ible in terms of distance travelled and the number of
weeks they had to wait for an appointment, or if they
had appropriate social supports. Potentially higher
out-of-pocket expenses incurred to attend a treatment
facility were presumed to deter patients from accessing
healthcare.
The cost parameter was designed to be broad, catering
for both public and private sector patients with cancer.
In Australia, patients will face varying levels of
healthcare-related costs depending on factors including:
(1) whether a primary care provider is bulk billing; (2)
the level of private health insurance coverage and (3)
the private copayment charges that are determined by
the individual specialists. We also have to take into
account additional expenses such as income loss with
time off work, the need for medical escorts, fuel and car
park expenses as well as accommodation (subsidised vs
own). The ﬁnal attributes and levels used in the choice
tasks are summarised in table 1.
Experimental design and construction of choice sets
The combination of attributes and levels in the study
resulted in (36=) 729 possible proﬁles (hence 7292 pos-
sible choice pairs). A full fractional design, incorporat-
ing all possible combinations, is, in some circumstances,
valuable because it enables all interaction effects to be
investigated. However, given the numbers of dimensions
and levels in this case, the full fractional design is not
appropriate, particularly for patients with cancer who
are unlikely to be able to consider a large number of
choice sets.
Thus, one author (RN) developed a smaller fractional
factorial design (FFD) in Ngene using the D-efﬁciency
criteria32 to select between competing designs. A
128-proﬁle FFD allowed us to select a set of choices,
which enabled exploration of the main effects (the
effect of each independent variable on the dependent
variable) and possible interactions (preferences for one
attribute depend on the level of another).33
A maximum of eight choice tasks per participant were
considered feasible, given the nature of the participants.
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Table 1 Final attributes and levels chosen for the discrete choice experiment
Attributes Descriptions Levels A priori expectations
Whom you consult for
your cancer condition:
Whether you see a specialist (medical oncologist,
radiation oncologist) for your cancer condition vs
your local general practitioner/nurse practitioner
with supervision from a specialist. The supervision
can occur through phone or email support, but you
do not actually see the specialist in person
Medical specialist in a cancer centre
Medical specialist in a general hospital
setting
Nurse practitioner or general practitioner with
support/advice from a medical specialist—
phone, email or video conference such as
telemedicine
In general, a positive preference for a
medical specialist in a cancer centre
compared with other healthcare
providers is expected
Whether the doctor
knows you:
This depends on how well the doctor knows you in
terms of your background and medical history
The doctor has access to your medical notes
and knows you well; for example, your usual
general practitioner or specialist
The doctor has access to your medical notes
but does not know you; for example, a locum
doctor at your usual general practitioner or
specialist practice
The doctor has no access to your medical
notes and does not know you; for example, a
new practice
In general, a negative preference for a
doctor who is not familiar with the
patient and patient’s medical history is
expected
Number of weeks you
have to wait to see a
doctor:
How long you have to wait to see a general
practitioner
1 week
3 weeks
6 weeks
In general, a positive preference for a
shorter waiting time is expected
The presence of family/
friends:
Whether you have the support of family/friends and
if they can escort you to your medical appointments
Family/friends can accompany you to the
appointments and stay with you overnight if
required
Family/friends can accompany you to the
appointments but are unable to stay with you
overnight if required
Family/friends are unable to accompany you
to the appointments
In general, a positive preference for the
presence of family/friends is expected
Distance you have to
travel for your
appointment (one-way):
How long it takes to travel to your appointment,
whether by public transport or private car, including
transit times
30 min
1–2 h
2–3 h
In general, a negative preference for a
longer travelling time is expected
Your out-of-pocket
costs in attending an
appointment:
These costs could include fuel, parking, meals,
accommodation if required and private co-payments
or medical gap expenses if seeing a private
specialist
$150
$300
$500
In general, a positive preference for
lower costs is expected
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While we believed that a proportion of participants
would be able to cope with more than eight choice
tasks, we felt other patients would struggle. We wanted
to ensure a broad representation of the patient popula-
tion in our DCE data; hence, we randomly blocked 128
choice sets into 16 sets of 8 choice tasks each. This
means that each participant answered only a subset of
the choice tasks from the FFD.
Some DCEs include an opt-out option or current care
as a third choice in the vignette; however, we chose not
to include an opt-out option because it was considered
to be unrealistic, given that we were recruiting patients
attending oncology services. Participants were asked to
choose their preferred appointment (appointment A vs
appointment B) for each choice task. An example of a
choice task is shown in ﬁgure 2.
Questionnaire design and DCE validity
The questionnaire opened with an introduction about
the purpose of the study. Importantly, a detailed descrip-
tion of each attribute and level was given before the
choice tasks were presented to help participants under-
stand what was required. Additional sociodemographic,
disease and treatment-related characteristics were col-
lected to assess how these characteristics might inﬂuence
choices.
Patient participants were also asked whether they
would allow the researchers to access data about them
collected by the Evaluation of Outcomes study (ECO),
which collects data items not limited to patient partici-
pant demographics (patient age, gender, geographical
location), medical condition and treatment adminis-
tered. ECO is a collaboration between the Victorian
Department of Health, the Cancer Council Victoria and
the Barwon South Western Regional Integrated Cancer
Service. An opt-out option was provided for patients who
chose not to have their ECO data accessed.
The face validity of the questionnaire was tested with
focus group patient participants, of which 10 out of 11
questionnaires were returned. This was then used to
reﬁne the comprehension, options and wording of the
DCE.20 Half of the participants felt that the question-
naire was confusing and difﬁcult to interpret, which sug-
gested that the questionnaire might be particularly
burdensome and cognitively demanding to our group of
patients. Subsequent changes to the text and layout were
made based on participants’ comments which included:
(1) the addition of an example choice task question to
demonstrate how to answer the questions and (2) a
reiteration that participants only choose one of the two
options.
The theoretical validity of the design will be explored
in the ongoing study by examining the signs and signiﬁ-
cance of parameter estimates. If the attributes are well
deﬁned, they will behave in line with a priori expecta-
tions, particularly in the dimensions where it is reason-
able to assert a monotonic relationship, such as cost.34
Participant sampling and recruitment
Sample size calculation for DCE studies in healthcare is
a developing ﬁeld, and one where rules of thumb
around observations per choice set are still employed.
Hall et al35 had suggested that 20–30 respondents per
choice set can provide precise parameter estimates,
while Lancsar and Louviere36 suggested that it is
unusual to require more than 20 observations per
choice set to estimate a reliable model. In this study,
with a design of 128 choice tasks in blocks of 8, this
would be achieved with a sample size of 320. Similarly,
Marshall et al37 estimated that a sample size of 100–300
respondents in healthcare could be appropriate given
the constraints on resources and speciﬁc medical condi-
tions, which may limit participation rates.
Eligibility criteria for participants in the DCE include:
patients with cancer over 18 years attending the BSWR
oncology services since January 2009, who are able to
read and write English and are willing and able to give
informed consent. We invited the three adult oncology
services across the BSWR (ALCC, Warrnambool and
Hamilton hospitals) to assist with participant recruit-
ment. Questionnaires were manually marked with a
unique letter to determine which oncology service had
distributed the questionnaires; this will allow us to
compare participation rates as well as variations in
characteristics and responses across metropolitan and
rural regions in patients with cancer.
We decided to allocate a larger number of question-
naires to metropolitan ALCC compared with rural
Warrnambool and Hamilton Hospitals, given that ALCC
services a higher proportion of patients, including
metropolitan and rural patients, and is the only treat-
ment facility across BSWR to provide radiotherapy
services.
Receptionists and HPs at the BSWR oncology services
will distribute the questionnaires to all eligible patients
when they check in for their appointments. Patient parti-
cipants will be given the options of completing the
questionnaire:
A. In the waiting room and to return the questionnaire
to reception staff where they will store the question-
naire in a secure storage container; OR
B. At home and to return the questionnaire with a
postage paid envelope to the care of one of the
researchers (SFW).
ANALYTICAL PLAN
A multinomial logit (MNL) model will be used to under-
stand the trade-offs between the features of cancer care
included in the choice tasks. The analysis of preferences
of patients with cancer towards an appointment will
allow us to investigate which patient and
healthcare-related factors (and levels) inﬂuence their
choices for cancer care. Their responses will also enable
us to establish the importance of these factors (and
levels) and their interactions with patient-related
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characteristics (age, gender, level of education and
income, the availability of social support networks,
non-English-speaking background, general health status
and experience with cancer).
An MNL approach was selected over a mixed MNL
approach for the baseline analysis, as it will allow us to
model the kind of preference heterogeneity we are
more interested in, speciﬁcally heterogeneity based on
the observed characteristics of patients in metropolitan
and rural regions. The mixed MNL has the added
advantage of allowing regression coefﬁcients to be
drawn from a distribution (and not determined by
observed characteristics). However, our study will focus
on predictable differences in preferences, so we will
employ the MNL approach for primary analysis,
although we intend to explore the data with the mixed
Figure 2 Structure of a discrete choice task.
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MNL and generalised MNL models,38 both of which can
be estimated in STATA due to the recently released
codes.39 40
The cost parameter will be modelled as a continuous
variable so that we can estimate the willingness to pay
(WTP) for moving between levels of each of the other
parameters. We can also estimate CIs around these WTP. 41
To explore differences in preferences between groups,
we will run a regression with each of the parameters
interacting with each of the sociodemographic
characteristics in turn. For example, we will interact a
binary metropolitan respondent variable with each of
the levels described in table 1 (with the exception of the
omitted level in each dimension).
To explore the impact of the sociodemographic char-
acteristic on preferences, we will test for the joint signiﬁ-
cance of the coefﬁcients on the interaction terms. We
will also run the models separately for the different
demographic groups (for instance, metropolitan and
rural respondents) and compare the resultant WTP
estimates.
ETHICS AND DISSEMINATION
All focus groups and one-on-one interview participants
were given a participant information and consent form
to ensure that they were fully informed about the nature
and objectives of the interviews and possible risks asso-
ciated with participation prior to the interviews and
digital recording.
Given that the DCE questionnaire will be distributed
to participants by non-research staff (receptionists and
non-research HPs), written consent for all participants is
not possible. The DCE opening page will inform poten-
tial participants that participation is voluntary and
should they decide to participate, they are to complete
and return the questionnaire via the two methods
described in the DCE. Contact details of the lead
researcher (SFW) will be available should they have any
questions.
All participants will be advised that any data generated
during the interviews and DCE questionnaire will be
conﬁdential and anonymous. All identiﬁable details will
be removed during future dissemination of the research
ﬁndings, in presentation and/or publication formats.
The DCE analysis will provide a comprehensive cover-
age of preferences of patients with cancer towards fea-
tures of their cancer care, and whether there is
preference heterogeneity by metropolitan and rural
locations. Speciﬁcally, these ﬁndings could be used to
improve on current provision of cancer healthcare to
patients across metropolitan and rural regions by:
A. Highlighting areas of preferred intervention from
the perspectives of patients with cancer. For example,
these issues may relate to early and increased provi-
sion of volunteer transport and subsidised accommo-
dation as well as ﬁnancial assistance to rural patients
with cancer who potentially face higher out-of-pocket
expenditures. Additional support for dependants of
cancer patients will alleviate some of the reservations
patients have about leaving home to access health-
care in a metropolitan facility;
B. Disseminating knowledge about the relative import-
ance of patient choices and increasing awareness of
the potential differences between metropolitan and
rural patients with cancer. These results will be pre-
sented at oncology conferences, that is, the
American Society of Clinical Oncology and the
Medical Oncology Group of Australia annual scien-
tiﬁc meetings, and published in peer-reviewed
journals;
C. Forming the basis of a pilot study to determine if and
how much choices of patients with cancer inﬂuence
their overall survival. Data from the DCE will be linked
to the ECO and analysed to determine if patient
choices could independently inﬂuence cancer out-
comes. These ﬁndings will inform the researchers of
the feasibility of conducting the study on a larger scale
to study choices of patients with cancer and their inter-
actions with other confounding variables.
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